Wegovy Approved in U.S. to Reduce Risk of Heart Attacks, Strokes
Wall Street Journal
Novo Nordisk can now begin promoting that its popular anti-obesity drug can also boost heart health–a claim that could increase pressure on reluctant employers and insurers to pay for the drug.
https://www.wsj.com/articles/wegovy-approved-in-u-s-to-reduce-risk-of-heart-attacks-strokes-38607555